Literature DB >> 21431893

Decompressive surgery for malignant supratentorial infarction remains underutilized after guideline publication.

Michal Bar1, Robert Mikulik, David Skoloudik, Daniel Czerny, Radim Lipina, Martin Sames, Milan Choc, Zdenek Novak, Marian Stary, Vladimir Benes, Martin Smrcka, Michal Filip, Denisa Vondrackova, Vladimir Chlouba, Petr Suchomel, Pavel Haninec, Richard Brzezny, Vilem Juran.   

Abstract

Decompressive surgery <48 h from stroke onset reduces the prevalence of mortality and morbidity from malignant supratentorial infarction. We investigated if utilization of decompressive surgery changed in the Czech Republic (CZ) after the release of new guidelines regarding treatment of malignant brain infarction. The volume of decompressive surgery in 2009 in all centers in the CZ was assessed using the same methodology as in 2006. All neurosurgery departments in the CZ were asked to complete a questionnaire and asked to identify all cases of decompressive surgery for malignant brain infarction through a combination of discharge codes for "brain infarction" and "decompressive surgery" from electronic hospital charts. Data for 56 patients were obtained from 15 of the 16 neurosurgery departments in the CZ. The average age was 53 ± 13; number of males 20; median time to surgery was 48 h (range 24-62); median NIHSS score was 25 (IQR, 20-30); median infarct volume was 300 cm(3) [interquartile (IQR, 250-350)]; mean shift on CT was 10.6 ± 3.6 mm and size of hemicraniectomy was 125 cm(2) (IQR, 110-154). A favorable outcome was achieved in 45% of the patients. The number of procedures increased from 39 in 2,006 to 2,056 in 2009. Based on data from one stroke center, 10% suffered from malignant supratentorial infarction and 2.3% met the criteria for decompressive surgery. In 2009, as compared to 2006, the volume of decompressive surgery carried out moderately increased. However, procedures remained underutilized because only ~10% of those who needed decompressive surgery underwent surgery.

Entities:  

Mesh:

Year:  2011        PMID: 21431893     DOI: 10.1007/s00415-011-6003-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  9 in total

1.  The rate of hemicraniectomy for acute ischemic stroke is increasing in the United States.

Authors:  Opeolu Adeoye; Richard Hornung; Pooja Khatri; Andrew Ringer; Dawn Kleindorfer
Journal:  J Stroke Cerebrovasc Dis       Date:  2010-07-10       Impact factor: 2.136

2.  'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs.

Authors:  W Hacke; S Schwab; M Horn; M Spranger; M De Georgia; R von Kummer
Journal:  Arch Neurol       Date:  1996-04

3.  Factors associated with outcome after hemicraniectomy for large middle cerebral artery territory infarction.

Authors:  William T Curry; Manish K Sethi; Christopher S Ogilvy; Bob S Carter
Journal:  Neurosurgery       Date:  2005-04       Impact factor: 4.654

4.  Predictors of fatal brain edema in massive hemispheric ischemic stroke.

Authors:  S E Kasner; A M Demchuk; J Berrouschot; E Schmutzhard; L Harms; P Verro; J A Chalela; R Abbur; H McGrade; I Christou; D W Krieger
Journal:  Stroke       Date:  2001-09       Impact factor: 7.914

5.  Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials.

Authors:  Katayoun Vahedi; Jeannette Hofmeijer; Eric Juettler; Eric Vicaut; Bernard George; Ale Algra; G Johan Amelink; Peter Schmiedeck; Stefan Schwab; Peter M Rothwell; Marie-Germaine Bousser; H Bart van der Worp; Werner Hacke
Journal:  Lancet Neurol       Date:  2007-03       Impact factor: 44.182

6.  Early mortality following stroke: a prospective review.

Authors:  F L Silver; J W Norris; A J Lewis; V C Hachinski
Journal:  Stroke       Date:  1984 May-Jun       Impact factor: 7.914

Review 7.  Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review.

Authors:  Rishi Gupta; E Sander Connolly; Stephan Mayer; Mitchell S V Elkind
Journal:  Stroke       Date:  2004-01-05       Impact factor: 7.914

8.  Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial.

Authors:  Eric Jüttler; Stefan Schwab; Peter Schmiedek; Andreas Unterberg; Michael Hennerici; Johannes Woitzik; Steffen Witte; Ekkehart Jenetzky; Werner Hacke
Journal:  Stroke       Date:  2007-08-09       Impact factor: 7.914

9.  Nationwide study of decompressive surgery for malignant supratentorial infarction in the Czech Republic: utilization and outcome predictors. Clinical article.

Authors:  Michal Bar; Robert Mikulik; David Skoloudík; Daniel Czerny; Radim Lipina; Lukas Klecka; Vilem Juran; Jan Mracek; Denisa Vondrácová; Lumir Hrabalek; Richard Brzezny; Jan Dienelt
Journal:  J Neurosurg       Date:  2010-10       Impact factor: 5.115

  9 in total
  5 in total

Review 1.  Early decompressive craniectomy for malignant cerebral infarction: Meta-analysis and clinical decision algorithm.

Authors:  Christopher D Streib; Linda M Hartman; Bradley J Molyneaux
Journal:  Neurol Clin Pract       Date:  2016-10

2.  A Cohort Study of Decompressive Craniectomy for Malignant Middle Cerebral Artery Infarction: A Real-World Experience in Clinical Practice.

Authors:  Zilong Hao; Xueli Chang; Hongqing Zhou; Sen Lin; Ming Liu
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

3.  Association between total antioxidant capacity and mortality in ischemic stroke patients.

Authors:  Leonardo Lorente; María M Martín; Antonia Pérez-Cejas; Pedro Abreu-González; Luis Ramos; Mónica Argueso; Juan J Cáceres; Jordi Solé-Violán; Alejandro Jiménez
Journal:  Ann Intensive Care       Date:  2016-04-23       Impact factor: 6.925

4.  Stroke-related complications in large hemisphere infarction: incidence and influence on unfavorable outcome.

Authors:  Jie Li; Ping Zhang; Simiao Wu; Yanfen Wang; Ju Zhou; Xingyang Yi; Chun Wang
Journal:  Ther Adv Neurol Disord       Date:  2019-08-30       Impact factor: 6.570

5.  Association between serum NLRP3 and malignant brain edema in patients with acute ischemic stroke.

Authors:  Yanan Wang; Hexiao Huang; Weihong He; Shihong Zhang; Ming Liu; Simiao Wu
Journal:  BMC Neurol       Date:  2021-09-07       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.